Detail page

Knowledge Web

Person

Björn Nashan (1960-)

Arzt

Name	Björn Nashan
Time	1960- (Date of birth and death)
Place	Oberhausen (Geburtsort) Hannover (Wirkungsort) Halifax (Wirkungsort) Hamburg-Eppendorf (Wirkungsort) Deutschland
Gender	männlich
Academic degree	Prof. Dr. med.
Profession	Arzt (characteristic profession) Chirurg Hochschullehrer
Related	Medizinische Hochschule Hannover Universitätsklinikum Hamburg-Eppendorf
Further information	seit 2004 Direktor des Multi Organ Transplant Program der Dalhousie Universität in Halifax, Kanada; Hochschullehrer für Chirurgie an der Medizinischen Hochschule Hannover; Univ. Hamburg, Medizinische Fak., Universitätsklinikum Hamburg-Eppendorf, Zentrum für Innere Medizin, Direktor der Klinik und Poliklinik für Hepatobiliäre Chirurgie und Transplantationschirurgie, 2007-
Source	http://microbiology.medicine.dal.ca/people/nashan
Record type	Person
GND-Identifier	13045902X
Record ID	13045902X
Involved in show all Early Everolimus-Facilitated Reduced Tacrolimus in Liver Transplantation : Results From the Randomized HEPHAISTOS Trial Differential regulation of extracellular matrix proteins in three recurrent liver metastases of a single patient with colorectal cancer Effect of everolimus‐based drug regimens on CMV‐specific T‐cell functionality after renal transplantation: 12‐month ATHENA subcohort‐study results Effect of everolimus-based drug regimens on CMV-specific T-cell functionality after renal transplantation : 12-month ATHENA subcohort-study results Organ donation : understanding successful models for organ donation and developing a roadmap to Germany Accuracy of pretransplant imaging diagnostic for hepatocellular carcinoma : a retrospective German multicenter study An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients High expression of micro RNA-135A in hepatocellular carcinoma is associated with recurrence within 12 months after resection The influence of PEEP and positioning on central venous pressure and venous hepatic hemodynamics in patients undergoing liver resection Design and rationale of the ATHENA study – A 12-month, multicentre, prospective study evaluating the outcomes of a de novo everolimus-based regimen in combination with reduced cyclosporine or tacrolimus versus a standard regimen in kidney transplant patients: study protocol for a randomised controlled trial Viral Hepatitis and Its Complications: Management of Hepatocellular Carcinoma Chirurgische Therapie des hilären Cholangiokarzinoms (Klatskin-Tumor) Evaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients: Study protocol for a randomized controlled trial Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a randomized, multidisciplinary, multinational phase III trial Is There a Role for Liver Transplantation in Non-Colorectal Liver Metastases? Rolle der hepatic arterial buffer response für das Hyperperfusionssyndrom bei der small-for-size Leber Chirurgisch-onkologische Therapie kolorektaler Lebermetastasen im Wandel der Zeit Extended pancreas donor program – the EXPAND study rationale and study protocol Chirurgie des intrahepatischen Cholangiokarzinoms Empfehlungen zu Diagnostik, Therapie und Prophylaxe von Infektionen sowie Impfungen nach Nierentransplantation Extended pancreas donor program : the EXPAND study rationale and study protocol Klinische und histologische Charakterisierung von Leberzelladenomen : eine retrospektive Analyse Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cells Hepatozelluläres Karzinom statt fokal noduläre Hyperplasie – ein Fallbericht Kolorektale Lebermetastasen : Therapiewahl ist abhängig vom Grad der Resektabilität Kolorektale Lebermetastasen : Therapiewahl ist abhängig vom Grad der Resektabilität Everolimus : Nachhaltigkeit in der De-novo-Immunsuppression bei Nierentransplantation Immunsuppressive Prophylaxe nach Lebertransplantation mit einem monoklonalen Antikörper gegen den IL-2 Rezeptor : funktionelle Untersuchungen zum Wirkungsmechanismus und Ergebnisse des klinischen Einsatzes Droperidol inhibits cardiac vagal efferents in dogs

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Björn Nashan (1960-)

Early Everolimus-Facilitated Reduced Tacrolimus in Liver Transplantation : Results From the Randomized HEPHAISTOS Trial

Differential regulation of extracellular matrix proteins in three recurrent liver metastases of a single patient with colorectal cancer

Effect of everolimus‐based drug regimens on CMV‐specific T‐cell functionality after renal transplantation: 12‐month ATHENA subcohort‐study results

Effect of everolimus-based drug regimens on CMV-specific T-cell functionality after renal transplantation : 12-month ATHENA subcohort-study results

Organ donation : understanding successful models for organ donation and developing a roadmap to Germany

Accuracy of pretransplant imaging diagnostic for hepatocellular carcinoma : a retrospective German multicenter study

An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients

An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients

High expression of micro RNA-135A in hepatocellular carcinoma is associated with recurrence within 12 months after resection

The influence of PEEP and positioning on central venous pressure and venous hepatic hemodynamics in patients undergoing liver resection

Viral Hepatitis and Its Complications: Management of Hepatocellular Carcinoma

Chirurgische Therapie des hilären Cholangiokarzinoms (Klatskin-Tumor)

Evaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients: Study protocol for a randomized controlled trial

Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a randomized, multidisciplinary, multinational phase III trial

Is There a Role for Liver Transplantation in Non-Colorectal Liver Metastases?

Rolle der hepatic arterial buffer response für das Hyperperfusionssyndrom bei der small-for-size Leber

Chirurgisch-onkologische Therapie kolorektaler Lebermetastasen im Wandel der Zeit

Extended pancreas donor program – the EXPAND study rationale and study protocol

Chirurgie des intrahepatischen Cholangiokarzinoms

Empfehlungen zu Diagnostik, Therapie und Prophylaxe von Infektionen sowie Impfungen nach Nierentransplantation

Extended pancreas donor program : the EXPAND study rationale and study protocol

Klinische und histologische Charakterisierung von Leberzelladenomen : eine retrospektive Analyse

Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cells

Hepatozelluläres Karzinom statt fokal noduläre Hyperplasie – ein Fallbericht

Kolorektale Lebermetastasen : Therapiewahl ist abhängig vom Grad der Resektabilität

Kolorektale Lebermetastasen : Therapiewahl ist abhängig vom Grad der Resektabilität

Everolimus : Nachhaltigkeit in der De-novo-Immunsuppression bei Nierentransplantation

Immunsuppressive Prophylaxe nach Lebertransplantation mit einem monoklonalen Antikörper gegen den IL-2 Rezeptor : funktionelle Untersuchungen zum Wirkungsmechanismus und Ergebnisse des klinischen Einsatzes

Droperidol inhibits cardiac vagal efferents in dogs